Telix Chooses IBA's Cyclone KIUBE for US Expansion
ByAinvest
Friday, Mar 20, 2026 2:02 am ET1min read
TLX--
IBA has signed a contract with Telix Pharmaceuticals for the delivery of four Cyclone KIUBE cyclotrons to RLS Radiopharmacies in the US. This investment supports Telix's strategic expansion in the US, enhancing its production capabilities and supply chain resilience. The Cyclone KIUBE 180 cyclotrons will be equipped with the QUANTM Irradiation System, allowing for the production of essential radioisotopes, such as Gallium-68, Zirconium-89, Technetium-99m, and Copper-64. The partnership aims to increase the availability of advanced diagnostic tools and improve patient outcomes.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet